Editorial
Parenteral Antiplatelets
JACC: Cardiovascular Interventions · 2026-02 · 19 (3) · 328-330
DOI: 10.1016/j.jcin.2025.12.013 ↗Kurz gefasst
Editorial in der Zeitschrift JACC: Cardiovascular Interventions, 2026-02. Verfasst von Zuzana Motovska und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cardiocenter, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
P2Y(12) inhibitorscangrelorcardiogenic shockglycoprotein IIb/IIIa inhibitorsmyocardial infarctionparenteral antiplateletsprognosis
Autor:innen und Institutionen
- Cardiocenter, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic.
- Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: dlbhattmd@post.harvard.edu.
Zitieren
APA
Motovska, Z., & Bhatt, D. L. (2026). Parenteral Antiplatelets. JACC: Cardiovascular Interventions, 19(3), 328-330. https://doi.org/10.1016/j.jcin.2025.12.013
Vancouver
Motovska Z, Bhatt DL. Parenteral Antiplatelets. JACC: Cardiovascular Interventions. 2026;19(3):328-330. doi:10.1016/j.jcin.2025.12.013
BibTeX
@article{Motovska2026,
author = {Motovska, Zuzana and Bhatt, Deepak L},
title = {Parenteral Antiplatelets},
journal = {JACC: Cardiovascular Interventions},
year = {2026},
volume = {19},
number = {3},
pages = {328--330},
doi = {10.1016/j.jcin.2025.12.013}
}
EUVIMED